What is Perfusion N-1 Culturing?

The N-1 perfusion method is a bioprocessing technique used in upstream biomanufacturing, particularly in the production of therapeutic proteins such as monoclonal antibodies (mAbs) in mammalian cell cultures like CHO (Chinese Hamster Ovary) cells.

---

What Does “N-1” Mean?

In cell culture bioprocessing, the N-1 stage refers to the penultimate step in the seed train — the series of culture steps used to expand cells before they enter the production bioreactor:

• N stage = final (production) bioreactor

• N-1 stage = step just before that, used to expand cells and prepare them for inoculation into the production reactor

---

 What Is Perfusion?

Perfusion is a cell culture method where fresh media is continuously added, and waste and byproducts are removed, while cells are retained in the bioreactor using a cell retention device (like an ATF—Alternating Tangential Flow—or TFF—Tangential Flow Filtration system).

This allows cells to stay in a healthy, growing phase and reach very high cell densities.

---

N-1 Perfusion: Definition

N-1 perfusion is the use of perfusion techniques at the N-1 stage (i.e., the seed bioreactor), to produce a large number of viable cells quickly. These cells are then used to inoculate the production bioreactor (N stage) at a much higher cell density than would be possible with conventional fed-batch expansion.

---

Why Use N-1 Perfusion?

Traditional seed train methods rely on fed-batch culture, which has limitations in the number of cells that can be grown due to nutrient depletion and waste accumulation. N-1 perfusion overcomes this by:

• Increasing cell density at the N-1 stage (often >100 million cells/mL)

• Reducing the size or number of production bioreactors needed

• Enabling intensified or continuous production strategies

• Improving process flexibility and facility utilization

---

 Benefits of N-1 Perfusion

1. High-Density Inoculation

   • Enables inoculation of the production bioreactor with much higher cell concentrations (e.g., >10 million cells/mL)

   • Leads to faster growth and earlier productivity in the N stage

2. Increased Throughput

   • Reduces turnaround time between batches

   • Allows multiple production bioreactors to be seeded from one N-1 perfusion system

3. Smaller Production Volumes

   • Higher productivity per volume allows use of smaller bioreactors or intensification of existing ones

4. Support for Continuous Bioprocessing

   • Acts as an enabler for continuous or semi-continuous manufacturing

---

How It’s Done (Simplified)

1. N-2 and earlier stages: Cells are expanded in standard fed-batch shake flasks or bioreactors.

2. N-1 stage (perfusion):

   • Cells are transferred to a bioreactor equipped with a cell retention device (like an ATF).

   • Fresh media is continuously perfused; waste is removed, cells are retained.

   • Cells grow to high density while maintaining high viability.

3. N stage (production):

   • The high-density culture is transferred to the production bioreactor.

   • Can be operated as fed-batch, perfusion, or intensified fed-batch.

---

Equipment & Technology

• Cell retention systems: Alternating Tangential Flow (ATF), Tangential Flow Filtration (TFF), acoustic filters

• Sensors & controls: For perfusion rate, cell density, viability, and metabolic profiling

• Single-use bioreactors: Commonly used in modern perfusion setups

---

Applications

• Monoclonal antibody production

• Gene therapy vectors

• Viral vaccine manufacturing

• Advanced therapies (CAR-T cells, exosomes, etc.)

---

 Challenges

• Complexity: More complicated to control than fed-batch

• Cost: Higher media consumption and equipment requirements

• Scalability: Must ensure consistent performance across scales

• Shear stress: Risk of damaging cells if perfusion is not well controlled

---

Summary Table